APIDRA PACKAGE INSERT PDF
Apidra SoloStar Units/ml solution for injection in a pre-filled pen – Patient The Patient Information Leaflet (PIL) is the leaflet included in the pack with a. Apidra SoloStar Units/ml solution for injection in a pre-filled pen . SoloStar, the Instructions for use included in the Package leaflet must be read carefully. APIDRA [insulin glulisine injection (rDNA origin)] is a recombinant . package insert, and the pump manufacturer’s manual (see DOSAGE AND.
|Published (Last):||28 July 2005|
|PDF File Size:||13.64 Mb|
|ePub File Size:||2.40 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hypoglycemia, sometimes resulting in coma, can occur. Severe hyperglycaemia or ketoacidosis must always be treated by a doctor, normally in a hospital.
Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen
The Apidra SoloStar is blue. What is in this leaflet 1. Acetaminophen; A;idra Phenyltoloxamine; Salicylamide: Blood glucose concentrations should be monitored more closely whenever a change in either nicotine intake or smoking status occurs; dosage adjustments in antidiabetic agents may be needed.
Turn the vial of insulin glulisine and syringe upside down. Specific maximum dosage information is not available.
In addition, during the perinatal period, careful monitoring of neonates born to mothers with diabetes is recommended. Insulin glulisine is equipotent to regular insulin, but with more rapid activity and a shorter duration of action when given via intermittent subcutaneous injection. Insulin glulisine exhibits a shorter duration of action, with a mean residence insulin time of 98 minutes compared to minutes with regular insulin.
Inhibitors of MAO type A have been shown to prolong the hypoglycemic response to insulin and oral sulfonylureas. The patient must have an alternative insulin delivery system in case of pump system failure.
How to use Apidra Dose Always use this medicine exactly as your doctor has told you. Always perform the safety test before each injection.
Hyperglycaemia high blood sugar means that there is too much sugar in the blood. Some patients with long-standing type 2 diabetes mellitus and heart disease or previous stroke who were treated with pioglitazone and insulin experienced the development of heart failure.
Patients taking antidiabetic agents and receiving bortezomib packagw may require close monitoring of their blood glucose levels and dosage adjustment of their medication. Moderate The risk of hypoglycemia is increased when lixisenatide is used in combination with insulin glulisine.
Careful monitoring of blood glucose is recommended.
Blood glucose monitoring is warranted in patients with type 2 diabetes prior to starting and during lorcaserin treatment. The dosing of antidiabetic agents may require adjustment in patients who receive cisapride concomitantly. Follow closely the instructions for dose, monitoring blood testsdiet and physical activity physical work and exercise as padkage with your doctor. The presence or absence of a concomitant progestin may influence the pqckage of any hormonal effect on glucose homeostasis.
Inform your doctor if you are planning to become pregnant, or if you are already pregnant.
Fast-Acting, Mealtime Insulin | Apidra® (insulin glulisine [rDNA origin] injection)
Put the outer needle cap back on the needle, and use it to unscrew the needle from the pen. As part of the glucose tolerance factor molecule, chromium appears to facilitate the binding of insulin to insulin receptors in tissues and to aid in glucose metabolism.
Insulin glulisine should not be diluted or mixed with any other insulins when used in an external pump. In addition, angiotensin II receptor antagonists have been associated with a reduced incidence in the development of new-onset packxge in patients with hypertension or other cardiac disease.
Use insulin glulisine in combination with intermediate- or long-acting insulin as part of twice-daily regimens or basal-bolus regimens. The apida duration of glycemic lowering effect in healthy subjects is minutes. Moderate In patients with diabetes mellitus, fluoxetine may alter glycemic control.
Insulin requirements are highly variable and must be individualized based on patient-specific factors and type of insulin regimen.
To reduce the risk of accidental needle injury, never replace the inner needle cap. Patients receiving insulin should be closely monitored for signs indicating loss of diabetic control when therapy with triamterene is instituted.
To prevent the possible transmission of disease, each pen must be used by one patient only. Always attach a new needle before each use.